These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

491 related items for PubMed ID: 20108337

  • 1. Pathogenesis of osteoblastic bone metastases from prostate cancer.
    Ibrahim T, Flamini E, Mercatali L, Sacanna E, Serra P, Amadori D.
    Cancer; 2010 Mar 15; 116(6):1406-18. PubMed ID: 20108337
    [Abstract] [Full Text] [Related]

  • 2. Intraosseous growth of human prostate cancer in implanted adult human bone: relationship of prostate cancer cells to osteoclasts in osteoblastic metastatic lesions.
    Yonou H, Ochiai A, Goya M, Kanomata N, Hokama S, Morozumi M, Sugaya K, Hatano T, Ogawa Y.
    Prostate; 2004 Mar 01; 58(4):406-13. PubMed ID: 14968441
    [Abstract] [Full Text] [Related]

  • 3. Pathogenesis and treatment of prostate cancer bone metastases: targeting the lethal phenotype.
    Loberg RD, Logothetis CJ, Keller ET, Pienta KJ.
    J Clin Oncol; 2005 Nov 10; 23(32):8232-41. PubMed ID: 16278478
    [Abstract] [Full Text] [Related]

  • 4. Prostate-specific antigen induces apoptosis of osteoclast precursors: potential role in osteoblastic bone metastases of prostate cancer.
    Goya M, Ishii G, Miyamoto S, Hasebe T, Nagai K, Yonou H, Hatano T, Ogawa Y, Ochiai A.
    Prostate; 2006 Nov 01; 66(15):1573-84. PubMed ID: 16927388
    [Abstract] [Full Text] [Related]

  • 5. Bone metastasis in prostate cancer: molecular and cellular mechanisms (Review).
    Ye L, Kynaston HG, Jiang WG.
    Int J Mol Med; 2007 Jul 01; 20(1):103-11. PubMed ID: 17549396
    [Abstract] [Full Text] [Related]

  • 6. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
    Feeley BT, Gamradt SC, Hsu WK, Liu N, Krenek L, Robbins P, Huard J, Lieberman JR.
    J Bone Miner Res; 2005 Dec 01; 20(12):2189-99. PubMed ID: 16294272
    [Abstract] [Full Text] [Related]

  • 7. Prostate cancer bone metastases promote both osteolytic and osteoblastic activity.
    Keller ET, Brown J.
    J Cell Biochem; 2004 Mar 01; 91(4):718-29. PubMed ID: 14991763
    [Abstract] [Full Text] [Related]

  • 8. Current trials using bone-targeting agents in prostate cancer.
    Tu SM, Lin SH.
    Cancer J; 2008 Mar 01; 14(1):35-9. PubMed ID: 18303481
    [Abstract] [Full Text] [Related]

  • 9. DU145 human prostate cancer cells express functional receptor activator of NFkappaB: new insights in the prostate cancer bone metastasis process.
    Mori K, Le Goff B, Charrier C, Battaglia S, Heymann D, Rédini F.
    Bone; 2007 Apr 01; 40(4):981-90. PubMed ID: 17196895
    [Abstract] [Full Text] [Related]

  • 10. Human prostatic tumor cells in culture produce growth and differentiation factors active on osteoblasts: a new biological and clinical parameter for prostatic carcinoma.
    Festuccia C, Teti A, Bianco P, Guerra F, Vicentini C, Tennina R, Villanova I, Sciortino G, Bologna M.
    Oncol Res; 1997 Apr 01; 9(8):419-31. PubMed ID: 9436195
    [Abstract] [Full Text] [Related]

  • 11. Canine prostate stimulates osteoblast function using the endothelin receptors.
    LeRoy BE, Sellers RS, Rosol TJ.
    Prostate; 2004 May 01; 59(2):148-56. PubMed ID: 15042615
    [Abstract] [Full Text] [Related]

  • 12. Osteoprotegerin in prostate cancer bone metastasis.
    Corey E, Brown LG, Kiefer JA, Quinn JE, Pitts TE, Blair JM, Vessella RL.
    Cancer Res; 2005 Mar 01; 65(5):1710-8. PubMed ID: 15753366
    [Abstract] [Full Text] [Related]

  • 13. [Mechanism of osteoblastic bone metastasis of prostate cancer].
    Yonou H, Ogawa Y, Ochiai A.
    Clin Calcium; 2006 Apr 01; 16(4):557- 64. PubMed ID: 16582505
    [Abstract] [Full Text] [Related]

  • 14. Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity.
    Kitagawa Y, Dai J, Zhang J, Keller JM, Nor J, Yao Z, Keller ET.
    Cancer Res; 2005 Dec 01; 65(23):10921-9. PubMed ID: 16322239
    [Abstract] [Full Text] [Related]

  • 15. The role of tumor microenvironment in prostate cancer bone metastasis.
    Morrissey C, Vessella RL.
    J Cell Biochem; 2007 Jul 01; 101(4):873-86. PubMed ID: 17387734
    [Abstract] [Full Text] [Related]

  • 16. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
    Fizazi K, Yang J, Peleg S, Sikes CR, Kreimann EL, Daliani D, Olive M, Raymond KA, Janus TJ, Logothetis CJ, Karsenty G, Navone NM.
    Clin Cancer Res; 2003 Jul 01; 9(7):2587-97. PubMed ID: 12855635
    [Abstract] [Full Text] [Related]

  • 17. Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway.
    Yang J, Fizazi K, Peleg S, Sikes CR, Raymond AK, Jamal N, Hu M, Olive M, Martinez LA, Wood CG, Logothetis CJ, Karsenty G, Navone NM.
    Cancer Res; 2001 Jul 15; 61(14):5652-9. PubMed ID: 11454720
    [Abstract] [Full Text] [Related]

  • 18. The bisphosphonate YM529 inhibits osteoblastic bone tumor proliferation of prostate cancer.
    Yonou H, Ochiai A, Ashimine S, Maeda H, Horiguchi Y, Yoshioka K, Ogawa Y, Hatano T, Tachibana M.
    Prostate; 2007 Jun 15; 67(9):999-1009. PubMed ID: 17440967
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms of tumor metastasis to the bone: challenges and opportunities.
    Reddi AH, Roodman D, Freeman C, Mohla S.
    J Bone Miner Res; 2003 Feb 15; 18(2):190-4. PubMed ID: 12568395
    [Abstract] [Full Text] [Related]

  • 20. Bone metastases in prostate cancer: a targeted approach.
    Storey JA, Torti FM.
    Curr Opin Oncol; 2007 May 15; 19(3):254-8. PubMed ID: 17414645
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.